Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Marcus

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
The Journal of Clinical Psychiatry|October 6, 2007
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baselineGary S Sachs, Bruce D Gaulin, Rolando Gutierrez-Esteinou, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 2, 2009
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled studyAllan H Young, Dan A Oren, Adam Lowy, et al.
The Journal of Clinical Psychiatry|February 8, 2014
A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorderRobert L Findling, Raymond Mankoski, Karen Timko, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic miceTakatoshi Mochizuki, Elda Arrigoni, Jacob N Marcus, et al.
Annals of Surgery|September 1, 1987
Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II)R J Fitzgibbons, H T Lynch, G V Stanislav, et al.
The Journal of Clinical Psychiatry|October 27, 2007
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placeboPaul E Keck, Joseph R Calabrese, Roger S McIntyre, et al.
Journal of Clinical Psychopharmacology|May 18, 2010
A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazoleFrederick W Reimherr, Michael L Martin, James M Eudicone, et al.
Neuropsychiatric Disease and Treatment|June 10, 2011
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorderRobert M Berman, Michael E Thase, Madhukar H Trivedi, et al.
CNS Spectrums|March 20, 2014
Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapyJ Craig Nelson, Zia Rahman, Kimberly K Laubmeier, et al.
The Journal of Clinical Psychiatry|July 9, 2008
A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapineJohn W Newcomer, Joao Alberto Campos, Ronald N Marcus, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Psychiatry|October 6, 2007
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baselineGary S Sachs, Bruce D Gaulin, Rolando Gutierrez-Esteinou, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 2, 2009
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled studyAllan H Young, Dan A Oren, Adam Lowy, et al.
The Journal of Clinical Psychiatry|February 8, 2014
A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorderRobert L Findling, Raymond Mankoski, Karen Timko, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic miceTakatoshi Mochizuki, Elda Arrigoni, Jacob N Marcus, et al.
Annals of Surgery|September 1, 1987
Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II)R J Fitzgibbons, H T Lynch, G V Stanislav, et al.
The Journal of Clinical Psychiatry|October 27, 2007
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placeboPaul E Keck, Joseph R Calabrese, Roger S McIntyre, et al.
Journal of Clinical Psychopharmacology|May 18, 2010
A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazoleFrederick W Reimherr, Michael L Martin, James M Eudicone, et al.
Neuropsychiatric Disease and Treatment|June 10, 2011
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorderRobert M Berman, Michael E Thase, Madhukar H Trivedi, et al.
CNS Spectrums|March 20, 2014
Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapyJ Craig Nelson, Zia Rahman, Kimberly K Laubmeier, et al.
The Journal of Clinical Psychiatry|July 9, 2008
A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapineJohn W Newcomer, Joao Alberto Campos, Ronald N Marcus, et al.
Pageof 23